Parkinsonism-dementia of Guam: treatment with L-dopa.
D000328:Adult; D003704:Dementia / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D007024:Hypotension, Orthostatic / Q000209:etiology; D008297:Male; D001523:Mental Disorders / Q000209:etiology; D008849:Micronesia; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy / Q000209:etiology; D010300:Parkinson Disease / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D010648:Phenylacetates / Q000134:cerebrospinal fluid; D044469:Racial Groups
D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine